Qube Research & Technologies LTD Matinas Bio Pharma Holdings, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$0.5 - $1.06 $29,761 - $63,094
-59,523 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$0.92 - $1.22 $54,761 - $72,618
59,523 New
59,523 $60,000
Q2 2021

Aug 13, 2021
SELL
$0.75 - $1.1 $16,732 - $24,541
-22,310 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$0.96 - $1.74 $37,564 - $68,086
-39,130 Reduced 63.69%
22,310 $23,000
Q4 2020

Feb 16, 2021
BUY
$0.76 - $1.47 $46,694 - $90,316
61,440 New
61,440 $84,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $128M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email